摘要
微量白蛋白尿(MAU)不仅是早期糖尿病肾病(DN)的标志,而且与心血管病变密切相关。MAU与心血管病变存在共同的病理生理基础,即内皮损伤。充分认识MAU的危害并进行积极防治,对于减少和延缓糖尿病心血管并发症的发生和发展具有重要意义。本综述旨在探讨MAU与糖尿病心血管病变的关系。
Microalbuminuria （MAU） is an early indication of diabetic nephropathy （DN）, and it＇s closely related to cardiovascular disease. MAU and cardiovascular disease share a common pathophysiological mechanism of endothelial dysfunction. Efficient control of MAU can reduce or delay the probability of cardiovascular complications in diabetes. This review with 30 referances aims to explore the relationship between MAU and cardiovascular disease in diabetes.
出处
《世界临床药物》
CAS
2010年第2期65-68,共4页
World Clinical Drug
关键词
微量白蛋白尿
糖尿病
心血管病变
内皮损伤
microalbuminuria
diabetes mellitus
cardiovascular disease
endothelial dysfunction
